文献速递气道管理

COVID-19地方性流行阶段的气道管理指南

Airway management guidance for the endemic phase of COVID-19.
PubMed 文献 · Anaesthesia · 2020-09-13

本文讨论SARS-CoV-2和COVID-19将长期地方性流行背景下气道管理的现状。强调需研究呼吸道气溶胶生成操作的性质与风险,并提高对病毒动力学和免疫的认识。当前证据不支持对麻醉气道管理选择做重大改变,患者与员工安全仍为首要。

要点

  • 当前证据不支持对麻醉气道管理选择做重大改变。
  • 需研究呼吸道气溶胶生成操作的性质与风险。
  • 手术室效率与培训问题需应对,新信息可能有助于解决。

核心结论

  • 当前证据不支持或不需要对麻醉气道管理选择做重大改变,患者与员工安全仍为首要。

主要发现

  • SARS-CoV-2和COVID-19将在一段时间内保持地方性流行。
  • 呼吸道气溶胶生成操作的性质与风险尚需研究明确。
  • 病毒动力学与免疫知识仍需提高。
  • 部分争议仍未解决。

临床怎么用

  • 在地方性流行阶段,气道管理应继续以患者与员工安全为首要。
  • 当前证据不支持对麻醉气道管理选择做重大改变。
  • 需关注手术室效率与培训问题。

局限性

  • 部分争议仍未解决。
  • 呼吸道气溶胶生成操作的性质与风险尚不明确。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

It is now apparent that severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) and coronavirus disease 2019 (COVID-19) will remain endemic for some time. Improved therapeutics and a vaccine may shorten this period, but both are far from certain. Plans must be put in place on the assumption that the virus and its disease will continue to affect the care of patients and the safety of staff. This will impact particularly on airway management due to the inherent risk to staff during such procedures. Research is needed to clarify the nature and risk of respiratory aerosol-generating procedures. Improved knowledge of the dynamics of SARS-CoV-2 infection and immunity is also required. In the meantime, we describe the current status of airway management during the endemic phase of the COVID-19 pandemic. Some controversies remain unresolved, but the safety of patients and staff remains paramount. Current evidence does not support or necessitate dramatic changes to choices for anaesthetic airway management. Theatre efficiency and training issues are a challenge that must be addressed, and new information may enable this.

来源:Anaesthesia,查看原文。版权归原作者所有。

引用

  1. Cook TM, McGuire B, Mushambi M, et al. Airway management guidance for the endemic phase of COVID-19. Anaesthesia. 2020. PMID: 32839960. doi:10.1111/anae.15253

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。